| Post | Subject | | |
#234790
|
138) OK, somebody is going to ask which
|
hptaxis
| 09/28/20 01:23:52 PM |
|
#234789
|
INO -37%/PM on news in #msg-158562894.
|
DewDiligence
| 09/28/20 09:28:09 AM |
|
#234765
|
Four Biotech Companies Are Going Public Today. What
|
biocqr
| 09/25/20 09:00:00 AM |
|
#234691
|
Quick comparison of PFE/BNTX, MRNA protocols:
|
DewDiligence
| 09/17/20 08:05:18 PM |
|
#234637
|
RVNC—Could you see that [a buyout] happening before
|
DewDiligence
| 09/15/20 12:06:31 PM |
|
#234805
|
Vincera goes public via reverse-merger with LSAC:
|
DewDiligence
| 09/29/20 09:42:07 AM |
|
#234804
|
IRWD discontinues GERD program for futility—35% workforce reduction:
|
DewDiligence
| 09/29/20 09:34:38 AM |
|
#234803
|
BiondVax ( BVXV)-has spent years developing and testing
|
midastouch017
| 09/29/20 08:07:15 AM |
|
#234802
|
OT Pandemic diary.... I'd missed the
|
IanFromSI
| 09/28/20 11:35:21 PM |
|
#234801
|
I see no RLFTF SEC-filings therefore not compliant.
|
RNsidersbuying
| 09/28/20 07:46:44 PM |
|
#234800
|
ABEO CEO and three other directors quit for
|
DewDiligence
| 09/28/20 05:25:06 PM |
|
#234799
|
JNJ > As Johnson & Johnson kick-starts phase
|
biocqr
| 09/28/20 05:03:11 PM |
|
#234798
|
Well RLFTF is on the OTC so do
|
Whalatane
| 09/28/20 04:38:35 PM |
|
#234797
|
Yes, but it will be a low proportion
|
DewDiligence
| 09/28/20 04:16:39 PM |
|
#234796
|
Thanks Dew. Are you expecting any revenue recorded
|
Bickema
| 09/28/20 04:10:10 PM |
|
#234795
|
$30M or more in 1Q20 product revenue (Daxi
|
DewDiligence
| 09/28/20 04:06:12 PM |
|
#234793
|
RVNC - Dew do you have any Q1
|
Bickema
| 09/28/20 03:26:25 PM |
|
#234792
|
Re: Which vaccine?
|
DewDiligence
| 09/28/20 02:10:07 PM |
|
#234791
|
tmo has been selected as third
|
57_2001
| 09/28/20 01:32:13 PM |
|
#234790
|
138) OK, somebody is going to ask which
|
hptaxis
| 09/28/20 01:23:52 PM |
|
#234789
|
INO -37%/PM on news in #msg-158562894.
|
DewDiligence
| 09/28/20 09:28:09 AM |
|
#234788
|
GNFT, LH ink collaboration for non-invasive NASH diagnostic:
|
DewDiligence
| 09/28/20 09:26:55 AM |
|
#234787
|
BIIB—Aducanumab advisory committee—>11/6/20:
|
DewDiligence
| 09/28/20 09:24:50 AM |
|
#234786
|
FDA has questions about INO’s COVID-19 vaccine trial:
|
DewDiligence
| 09/28/20 07:12:25 AM |
|
#234785
|
ROTH Webinar - Enanta Pharmaceuticals (ENTA) - Registration
|
floblu14
| 09/28/20 06:48:46 AM |
|
#234784
|
Revance price target raised to $35 from $32
|
floblu14
| 09/28/20 06:40:54 AM |
|
#234783
|
quite a gamble to hold
|
57_2001
| 09/27/20 04:36:31 PM |
|
#234782
|
AQST receives CRL for Libervant:
|
DewDiligence
| 09/26/20 01:24:35 PM |
|
#234781
|
sept 30 seems to be tied to
|
57_2001
| 09/26/20 01:04:33 PM |
|
#234780
|
HGEN 9.77 - interesting. How many other SEC-compliant-stocks
|
RNsidersbuying
| 09/26/20 12:05:02 PM |
|
#234779
|
KOD. Baker Bros upping their position again
|
Whalatane
| 09/25/20 06:35:01 PM |
|
#234778
|
Scorecard for today’s biotech IPOs…
|
DewDiligence
| 09/25/20 05:54:31 PM |
|
#234776
|
own small amount of both relief (rlftf) and hgen.
|
57_2001
| 09/25/20 02:29:07 PM |
|
#234774
|
not sure, however if it is going well,
|
57_2001
| 09/25/20 02:12:09 PM |
|
#234773
|
Is the still recruiting on your link correct?
|
randychub
| 09/25/20 02:02:40 PM |
|
#234772
|
note p-3 should be complete sept 2020
|
57_2001
| 09/25/20 01:49:29 PM |
|
#234771
|
ORPHA.CO’s US IPO delayed until 9/28/20:
|
DewDiligence
| 09/25/20 11:13:18 AM |
|
#234770
|
PVMP IPOs 13.53M* shares @$18.00:
|
DewDiligence
| 09/25/20 11:12:51 AM |
|
#234769
|
PRLD IPOs 9.57M* shares @$19.00:
|
DewDiligence
| 09/25/20 11:12:25 AM |
|
#234768
|
GLSI IPOs 1.45M* shares @$5.75:
|
DewDiligence
| 09/25/20 11:12:02 AM |
|
#234767
|
GRAY IPOs 6.47M* shares @$16.00:
|
DewDiligence
| 09/25/20 11:10:42 AM |
|
#234766
|
one of about forty companies in the
|
57_2001
| 09/25/20 10:22:35 AM |
|
#234765
|
Four Biotech Companies Are Going Public Today. What
|
biocqr
| 09/25/20 09:00:00 AM |
|
#234764
|
...and there's been a flood of PRs from
|
IanFromSI
| 09/24/20 10:34:38 PM |
|
#234763
|
UK may start COVID-19 vaccine 'challenge studies'
|
Biowatch
| 09/24/20 09:06:35 PM |
|
#234762
|
Opdivo monotherapy—>statsig-superior DFS—against placebo—in adjuvant UC:
|
DewDiligence
| 09/24/20 05:05:15 PM |
|
#234761
|
Revenue for ABT—boost for overall economy:
|
DewDiligence
| 09/24/20 02:20:11 PM |
|
#234760
|
Chart looks terrible, and Comp. may be *terrible*
|
miljenko
| 09/24/20 11:35:00 AM |
|
#234759
|
TSHA IPOs 9.05M* shares @$20.00:
|
DewDiligence
| 09/24/20 11:29:50 AM |
|
#234758
|
seschm,
At this point I'm not inclined to sell
|
jbog
| 09/23/20 08:32:57 PM |
|
#234757
|
you mentioned earlier that you planned to take
|
seschm
| 09/23/20 05:32:17 PM |
|
#234756
|
I was in excel a couple of years
|
jbog
| 09/23/20 04:54:00 PM |
|
#234755
|
WVE -37% on sharply discounted $115M* financing:
|
DewDiligence
| 09/23/20 04:46:18 PM |
|
#234754
|
Haven't sold a share and have bought any
|
vinmantoo
| 09/23/20 04:23:24 PM |
|
#234753
|
Vin,
I know that jbog can answer for himself,
|
vinmantoo
| 09/23/20 04:14:33 PM |
| Post | Subject | | |